M. Ugolotti

ORCID: 0000-0003-0170-159X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Allergic Rhinitis and Sensitization
  • Lipoproteins and Cardiovascular Health
  • Indoor Air Quality and Microbial Exposure
  • Computational Drug Discovery Methods
  • Lichen and fungal ecology
  • Antifungal resistance and susceptibility
  • Plant Pathogens and Fungal Diseases
  • Plant Ecology and Soil Science
  • Advanced Chemical Sensor Technologies
  • Cholinesterase and Neurodegenerative Diseases
  • Infection Control in Healthcare
  • Cancer, Lipids, and Metabolism
  • Surgical site infection prevention
  • Medical Device Sterilization and Disinfection
  • Odor and Emission Control Technologies
  • Alzheimer's disease research and treatments
  • Inhalation and Respiratory Drug Delivery
  • Building materials and conservation
  • Cholesterol and Lipid Metabolism
  • Nematode management and characterization studies
  • Conservation Techniques and Studies

University of Parma
2012-2024

Ambrosia is an annual anemophilous weed producing allergenic pollen affecting public health in European countries. In Italy, the most infested region Lombardy where, some areas, it major cause of hay fever. Parma district, until 2007, seemed to be very rare, despite observed increase Seasonal Pollen Index (SPI), peak value and asthma among ragweed sensitized patients. The aims this study were calculate season trends from 1996 2015, assess relationships between characteristics selected...

10.7416/ai.2017.2182 article EN PubMed 2017-10-20

Aim: Impairment of cholesterol homeostasis is one the multiple etiopathological mechanisms at origin both cardiovascular and neurodegenerative diseases. The PCSK9 protein, known for its role in degradation hepatic LDLR plasma regulation, expressed also CNS, where it exacerbates -amyloid neurotoxicity reduces neuronal uptake, suggesting an involvement AD. This study proposes vitro screening molecules (MR) with inhibitory activity on PCSK9, selecting best compounds to test their cerebral cell...

10.56095/eaj.v2i1.43 article EN cc-by-nc-nd European Atherosclerosis Journal 2023-04-30
Coming Soon ...